JPS62120388A - Ｓｆ−２３７０物質ハロゲン化誘導体とその製造法 - Google Patents

Ｓｆ−２３７０物質ハロゲン化誘導体とその製造法

Info

Publication number
JPS62120388A
JPS62120388A JP25765285A JP25765285A JPS62120388A JP S62120388 A JPS62120388 A JP S62120388A JP 25765285 A JP25765285 A JP 25765285A JP 25765285 A JP25765285 A JP 25765285A JP S62120388 A JPS62120388 A JP S62120388A
Authority
JP
Japan
Prior art keywords
substance
formula
atom
chlorine
bromine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP25765285A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0215555B2 (https=
Inventor
Masao Koyama
小山　正夫
Mitsugi Hachisu
蜂須　貢
Michiaki Iwata
道顕 岩田
Michio Kojima
小嶋　道男
Fumio Kai
甲斐　文夫
Masaji Sezaki
瀬崎　正次
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Priority to JP25765285A priority Critical patent/JPS62120388A/ja
Publication of JPS62120388A publication Critical patent/JPS62120388A/ja
Publication of JPH0215555B2 publication Critical patent/JPH0215555B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP25765285A 1985-11-19 1985-11-19 Ｓｆ−２３７０物質ハロゲン化誘導体とその製造法 Granted JPS62120388A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP25765285A JPS62120388A (ja) 1985-11-19 1985-11-19 Ｓｆ−２３７０物質ハロゲン化誘導体とその製造法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25765285A JPS62120388A (ja) 1985-11-19 1985-11-19 Ｓｆ−２３７０物質ハロゲン化誘導体とその製造法

Publications (2)

Publication Number Publication Date
JPS62120388A true JPS62120388A (ja) 1987-06-01
JPH0215555B2 JPH0215555B2 (https=) 1990-04-12

Family

ID=17309220

Family Applications (1)

Application Number Title Priority Date Filing Date
JP25765285A Granted JPS62120388A (ja) 1985-11-19 1985-11-19 Ｓｆ−２３７０物質ハロゲン化誘導体とその製造法

Country Status (1)

Country Link
JP (1) JPS62120388A (https=)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63295588A (ja) * 1987-01-22 1988-12-01 Kyowa Hakko Kogyo Co Ltd 生理活性物質ｋ−２５２の誘導体
US4877776A (en) * 1987-12-24 1989-10-31 Kyowa Hakko Kogyo Co., Ltd. K-252 compounds
US4923986A (en) * 1987-03-09 1990-05-08 Kyowa Hakko Kogyo Co., Ltd. Derivatives of physiologically active substance K-252
WO1994006799A1 (en) * 1992-09-21 1994-03-31 Kyowa Hakko Kogyo Co., Ltd. Thrombocytopenia remedy
WO1994016706A1 (en) 1993-01-28 1994-08-04 Neorx Corporation Therapeutic inhibitors of vascular smooth muscle cells
US5599808A (en) * 1994-02-18 1997-02-04 Cephalon, Inc. Aqueous indolocarbazole solutions
US5618809A (en) * 1989-12-14 1997-04-08 Schering Corporation Indolocarbazoles from saccharothrix aerocolonigenes copiosa subsp. nov SCC 1951 ATCC 53856
US5621101A (en) * 1992-07-24 1997-04-15 Cephalon, Inc. Protein kinase inhibitors for treatment of neurological disorders
US5741808A (en) * 1992-07-24 1998-04-21 Cephalon, Inc. Protein kinase inhibitors for treatmen of neurological disorders
US6184217B1 (en) 1996-06-25 2001-02-06 Cephalon, Inc. Use of K-252a derivative
US6200968B1 (en) 1998-08-06 2001-03-13 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
US6306849B1 (en) 1996-06-03 2001-10-23 Cephalon, Inc. Selected derivatives of K-252a
US6875865B1 (en) 1996-06-03 2005-04-05 Cephalon, Inc. Selected derivatives of K-252a
EP2098230A1 (en) 1997-03-31 2009-09-09 Boston Scientific Scimed Limited Use of cytoskeletal inhibitors in crystalline form for the inhibition or prevention of restenosis
US7795246B2 (en) 1998-08-06 2010-09-14 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
EP2292225A1 (en) 1997-03-31 2011-03-09 Boston Scientific Scimed Limited Dosage form comprising taxol in crystalline form

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63295588A (ja) * 1987-01-22 1988-12-01 Kyowa Hakko Kogyo Co Ltd 生理活性物質ｋ−２５２の誘導体
US4923986A (en) * 1987-03-09 1990-05-08 Kyowa Hakko Kogyo Co., Ltd. Derivatives of physiologically active substance K-252
US4877776A (en) * 1987-12-24 1989-10-31 Kyowa Hakko Kogyo Co., Ltd. K-252 compounds
US5618809A (en) * 1989-12-14 1997-04-08 Schering Corporation Indolocarbazoles from saccharothrix aerocolonigenes copiosa subsp. nov SCC 1951 ATCC 53856
US5741808A (en) * 1992-07-24 1998-04-21 Cephalon, Inc. Protein kinase inhibitors for treatmen of neurological disorders
US5756494A (en) * 1992-07-24 1998-05-26 Cephalon, Inc. Protein kinase inhibitors for treatment of neurological disorders
US5621101A (en) * 1992-07-24 1997-04-15 Cephalon, Inc. Protein kinase inhibitors for treatment of neurological disorders
WO1994006799A1 (en) * 1992-09-21 1994-03-31 Kyowa Hakko Kogyo Co., Ltd. Thrombocytopenia remedy
WO1994016706A1 (en) 1993-01-28 1994-08-04 Neorx Corporation Therapeutic inhibitors of vascular smooth muscle cells
EP2324829A1 (en) 1993-01-28 2011-05-25 Boston Scientific Limited Therapeutic inhibitors of vascular smooth muscle cells
US5599808A (en) * 1994-02-18 1997-02-04 Cephalon, Inc. Aqueous indolocarbazole solutions
US6306849B1 (en) 1996-06-03 2001-10-23 Cephalon, Inc. Selected derivatives of K-252a
US6875865B1 (en) 1996-06-03 2005-04-05 Cephalon, Inc. Selected derivatives of K-252a
US6184217B1 (en) 1996-06-25 2001-02-06 Cephalon, Inc. Use of K-252a derivative
EP2098230A1 (en) 1997-03-31 2009-09-09 Boston Scientific Scimed Limited Use of cytoskeletal inhibitors in crystalline form for the inhibition or prevention of restenosis
EP2292225A1 (en) 1997-03-31 2011-03-09 Boston Scientific Scimed Limited Dosage form comprising taxol in crystalline form
US6200968B1 (en) 1998-08-06 2001-03-13 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
US7795246B2 (en) 1998-08-06 2010-09-14 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles

Also Published As

Publication number Publication date
JPH0215555B2 (https=) 1990-04-12

Similar Documents

Publication Publication Date Title
JPS62120388A (ja) Ｓｆ−２３７０物質ハロゲン化誘導体とその製造法
DE69129193T2 (de) Triterpenderivat
CN104817605B (zh) 2‑（1’,2’,3’‑三氮唑‑4’‑氧苄基）‑1,3,4,6‑o‑乙酰基‑d‑葡萄糖及其制备方法和应用
JPS6123192B2 (https=)
JPS61103890A (ja) ６−０−メチルエリスロマイシンａ誘導体
EP0296975A1 (fr) Dérivés du diméthyl-2,2 chromannol-3, procédé d'obtention et compositions pharmaceutiques les contenant
CN106749494A (zh) 具有肿瘤耐药逆转活性的α‑常春藤皂苷元衍生物及其制备方法和用途
CN101724007B (zh) 齐墩果酸衍生物及其作为α-葡萄糖苷酶抑制剂的用途
Ponnusamy et al. Drug efficacy of novel 3-O-methoxy-4-halo disubstituted 5, 7-dimethoxy chromans; evaluated via DNA gyrase inhibition, bacterial cell wall lesion and antibacterial prospective
US4430355A (en) Condensed isothiazolo-3 (2H)-one-1-1-dioxides
CN113698378A (zh) 一类萘醌类化合物及其制备与杀螨、杀菌用途
JPH0327534B2 (https=)
CN113788831A (zh) 二氢吲嗪并吡咯酮衍生物及类似物及其合成方法
CN106995450A (zh) 一种雷公藤甲素衍生物及其制备方法和用途
CN114097804B (zh) 一种二氨基嘧啶类化合物在防治农业病原菌中的用途
JP4038245B2 (ja) 新規なフェナンスリジニウム誘導体
US5668168A (en) 1,2-dithiin antiinfective agents
CN107652338B (zh) 糖偶联-1,2,3-三氮唑取代的多环芳烃衍生物在制备抗癌药物的用途
US3641146A (en) Halocolchicine derivatives
DE1670377B2 (de) Verfahren zur herstellung von rifamycinderivaten
CZ282419B6 (cs) Způsob výroby benzo/c/fenantridiniových derivátů a nové sloučeniny připravené tímto způsobem
NarasimhaáRao Oxidative demethylation of 4-substituted N, N-dimethylanilines with iodine and calcium oxide in the presence of methanol
CN116063373B (zh) 天然产物27-Deoxywithaferin A的制备方法
CN107641141B (zh) 糖偶联-1,2,3-三氮唑取代的多环芳烃衍生物及制备方法
CN110317179B (zh) 类赤霉素化合物、其制备方法、药物组合物及应用及其中间体